DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Appau KA, Fazio VW, Shen B. et al
Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn’s patients.
Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 2008; 12: 1738-1744
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.